For the past 15 years the Biostatistics Shared Resource has played a vital role in the research life of the UWCCC Members of the Shared Resource are an essential component in each of the research program from the laboratory bench through to the clinic. Dr. Mary Lindstrom and Michael Newton specialize in laboratory collaboration. Their contributions have induced a new method for assessing gene loss (Newton) and a new approach to comparing radiation cell survival curves (Lindstrom). Drs. David Demets and Richard Chappell and, before leaving, Barry Storer, play an essential role in the conduct of clinical research in the UWCCC. Stored developed new methods for phase I and II design now being continued by DeMets. DeMets has developed data monitoring methods for phase II and III trials which has been used extensively by researcher at the UWCCC and internationally. Chappell has developed a new model for therapeutic radiation damage to tumors. Drs. Jeffrey Douglas, DeMets, and Polly Newcomb have also been very active in Cancer Control, primarily with population, measurement and analysis issues concerning cancer symptoms such as pain and fatigue and a variety of epidemiological issues. These and other collaborators have resulted in 68 collaborative publications in the four years 1993-1996. One of the strengths of the UWCCC is the involvement of biostatisticians from the initial stages of project development to the completion of the project. The shared resource staff function as collaborative members of research teams drawing a portion of their support from peer reviewed grants. This approach, with its emphasis on collaboration, maximizes the benefit of the resource and helps foster and retain an expert, motivated and innovative staff committed to their specific areas of collaboration. Funds from the CCSSG are critical in maintaining this shared resource, encouraging investigators to seek our support for advice and expertise in the initial stages of a project. The initial stage of a project is critical to get the experimental design established so that the completed experiment can be properly analyzed and sensibly interpreted.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-27
Application #
6101616
Study Section
Project Start
1999-04-16
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
27
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Xu, Cheng; Chen, Feng; Valdovinos, Hector F et al. (2018) Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. Biomaterials 165:56-65
Wargowski, Ellen; Johnson, Laura E; Eickhoff, Jens C et al. (2018) Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine. J Immunother Cancer 6:21
Bednarz, Bryan; Grudzinski, Joseph; Marsh, Ian et al. (2018) Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Phys 114:450-459
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
van den Broek, Jeroen J; van Ravesteyn, Nicolien T; Mandelblatt, Jeanne S et al. (2018) Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. Med Decis Making 38:140S-150S
Lu, Zhanping; Hong, Courtney C; Kong, Guangyao et al. (2018) Polycomb Group Protein YY1 Is an Essential Regulator of Hematopoietic Stem Cell Quiescence. Cell Rep 22:1545-1559
Shea, Michael P; O'Leary, Kathleen A; Fakhraldeen, Saja A et al. (2018) Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER?+ Mammary Carcinomas. Cancer Res 78:1672-1684
Schrager, Sarina; Burnside, Elizabeth (2018) Breast Cancer Screening in Primary Care: A Call for Development and Validation of Patient-Oriented Shared Decision-Making Tools. J Womens Health (Larchmt) :
Ehlerding, Emily B; Grodzinski, Piotr; Cai, Weibo et al. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:2106-2121
Liu, Bai; Jones, Monica; Kong, Lin et al. (2018) Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Cytokine 107:105-112

Showing the most recent 10 out of 1528 publications